What are your top takeaways from ISTH 2025?   

MAYARI trial - this trial was a single-arm trial for "non-severe" iTTP (excluding patients with significant cardiac or neurologic involvement) where PLEX was only used as a rescue therapy. Patients were started on caplacizumab and immunosuppression with steroids and rituximab. A large number of ...

Session code 13394 - Extended Reduced vs Full Dose oral anticoagulant after VTE in obese patients (RENOVE trial) Session code 12636 - Bleeding risk on rivaroxaban and apixaban in older patients with VTE (Roupe et al.) Session Code 14299 - Major surgical outcomes with efanesoctocog alfa (Kla...